United Therapeutics | UTHR - Current Liabilities


United Therapeutics reported $560.6M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Amarin USD 194.46M 12.23M Dec/2025
Ardelyx USD 88.6M 5.22M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
BioCryst Pharmaceuticals USD 196.07M 5.83M Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Emergent BioSolutions USD 651.3M 12.7M Dec/2023
Esperion Therapeutics USD 300.81M 58.22M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Insmed USD 468.87M 51.66M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Lexicon Pharmaceuticals USD 20.87M 853K Dec/2025
Moderna USD 1.99B 306M Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Pfizer USD 36.6B 1.13B Sep/2025
PTC Therapeutics USD 968.43M 102.18M Dec/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sarepta Therapeutics USD 1.1B 173.86M Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
United Therapeutics USD 560.6M 14.3M Dec/2025
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025